News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
238
Sources here
19
Companies here
15
Search results Stored financial headlines

Active search

238 matching headlines

Ticker or company: URUMain company stories
Clear
Latest

Investing.com Earnings

CarGurus CEO Jason Trevisan sells $45,166 in Class A common stock

CarGurus CEO Jason Trevisan sold 1,100 shares of Class A common stock totaling $45,166 on August 7, 2026, pursuant to a Rule 10b5-1 trading plan. The sale occurred near the stock's 52-week high, while CarGurus shows strong financial health with impressive gross profit margins and recently surpassed analyst expectations for Q2 2026 earnings. The company has also launched …

CarGurus director Greg M. Schwartz disposes of Class A shares worth $360,700

CarGurus director Greg M. Schwartz sold 10,000 Class A common shares on August 12, 2026, for a total value of $360,700. Following this transaction, Schwartz now holds 8,716 Class A common shares in the company. This news brief was generated by AI based on …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

CarGurus Director Greg Schwartz Executes Sale of 10,000 Shares at $36.07 Average Price

Greg M. Schwartz, a director at CarGurus, Inc. (NASDAQ: CARG), sold 10,000 shares of Class A Common Stock on August 12, 2026, at a weighted average price of $36.07 per share. This transaction, revealed in a Form 4 filing with the SEC, leaves Schwartz …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

We're Keeping An Eye On Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Cash Burn Rate

This article examines Arcturus Therapeutics Holdings' cash burn rate and its implications for the company's future. It highlights the company's current cash reserves and how long they might last given its operating expenses. The analysis is crucial for investors to understand the company's financial …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus (CARG) holder files to sell 8,957 Class A shares via Rule 144

CarGurus, Inc. (CARG) has filed a notice under SEC Rule 144 for the proposed sale of 8,957 Class A shares, which will be executed through Fidelity Brokerage Services LLC. These shares are related to restricted stock that vested or is scheduled to vest on …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wellington updates CarGurus (CARG) beneficial ownership to 4.28% of common stock

Wellington Management Group LLP and its related entities have filed an amended Schedule 13G/A, reporting beneficial ownership of 3,255,283 shares of CarGurus, Inc. (CARG) common stock, which represents 4.28% of the class. The filing indicates that all voting and dispositive powers are shared, with …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CARG (CARG) investor files to sell 10,000 Class A shares via Form 144

A CarGurus (CARG) Class A stock holder has filed a Form 144 notice to sell up to 10,000 Class A shares, with an aggregate market value of $360,670.36, starting on August 12, 2026. These shares originate from restricted stock vesting awards tied to compensation, …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline

Arcturus Therapeutics is focusing its mRNA platform on rare diseases like cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency, utilizing its vaccine business to fund these therapeutic developments. The company expects to decide on advancing its inhaled mRNA treatment for CF (ARCT-032) into Phase …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Hold Rating, Maintains Target Price $9

H.C. Wainwright has reiterated its Hold rating on Arcturus Therapeutics (ARCT.US) and maintained its target price at $9. This indicates that the firm sees the stock as likely to perform in line with the broader market and does not anticipate significant price movement from …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus Names 2026 Top Dealer Award Winners

CarGurus, Inc. The 12th annual awards recognize dealers delivering outstanding service, value, and transparency, with less than 10% of dealerships earning the distinction BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- CarGurus (Nasdaq: CARG), the No. 1 most visited automotive shopping site in the U.S.,¹ …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus, Inc. $CARG Shares Sold by Amundi

Amundi reduced its stake in CarGurus, Inc. (NASDAQ:CARG) by 79.5% in the first quarter, selling 77,293 shares and retaining 19,878 shares. Despite this, institutional investors still hold 86.9% of the company, and analyst sentiment remains positive with a "Moderate Buy" rating and an average …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics (NASDAQ:ARCT) Rating Increased to Sell at Wall Street Zen

Wall Street Zen upgraded Arcturus Therapeutics (ARCT) from "strong sell" to "sell," while Weiss Ratings maintained its "sell (D-)" rating. Despite these downgrades, MarketBeat's analyst consensus remains a "Moderate Buy" with an average price target of $24.25. The clinical-stage biotech company, which develops mRNA …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus (CARG) Stock Rally Masks A Sharper Margin Squeeze

CarGurus (CARG) saw its stock jump 7.2% after its Q2 earnings report, driven by strong revenue and non-GAAP EPS. However, the article highlights a significant margin squeeze, with the trailing net profit margin dropping to 22% from 29.7% a year ago, which is a …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context